291 related articles for article (PubMed ID: 26452067)
21. Isoflurane-induced neuroinflammation and NKCC1/KCC2 dysregulation result in long-term cognitive disorder in neonatal mice.
Xu D; Liu J; Meng S; Sun M; Chen Y; Hong Y
BMC Anesthesiol; 2024 Jun; 24(1):200. PubMed ID: 38840092
[TBL] [Abstract][Full Text] [Related]
22. BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion.
Rivera C; Li H; Thomas-Crusells J; Lahtinen H; Viitanen T; Nanobashvili A; Kokaia Z; Airaksinen MS; Voipio J; Kaila K; Saarma M
J Cell Biol; 2002 Dec; 159(5):747-52. PubMed ID: 12473684
[TBL] [Abstract][Full Text] [Related]
23. Developmental Expression Patterns of KCC2 and Functionally Associated Molecules in the Human Brain.
Sedmak G; Jovanov-Milošević N; Puskarjov M; Ulamec M; Krušlin B; Kaila K; Judaš M
Cereb Cortex; 2016 Dec; 26(12):4574-4589. PubMed ID: 26428952
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of novel bumetanide derivatives for epilepsy treatment.
Auer T; Schreppel P; Erker T; Schwarzer C
Neuropharmacology; 2020 Jan; 162():107754. PubMed ID: 31476353
[TBL] [Abstract][Full Text] [Related]
25. Compromised GABAergic inhibition contributes to tumor-associated epilepsy.
MacKenzie G; O'Toole KK; Moss SJ; Maguire J
Epilepsy Res; 2016 Oct; 126():185-96. PubMed ID: 27513374
[TBL] [Abstract][Full Text] [Related]
26. Bumetanide reduce the seizure susceptibility induced by pentylenetetrazol via inhibition of aberrant hippocampal neurogenesis in neonatal rats after hypoxia-ischemia.
Hu JJ; Yang XL; Luo WD; Han S; Yin J; Liu WH; He XH; Peng BW
Brain Res Bull; 2017 Apr; 130():188-199. PubMed ID: 28161194
[TBL] [Abstract][Full Text] [Related]
27. BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model.
Eftekhari S; Mehrabi S; Soleimani M; Hassanzadeh G; Shahrokhi A; Mostafavi H; Hayat P; Barati M; Mehdizadeh H; Rahmanzadeh R; Hadjighassem MR; Joghataei MT
Acta Neurobiol Exp (Wars); 2014; 74(3):276-87. PubMed ID: 25231847
[TBL] [Abstract][Full Text] [Related]
28. Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy.
Sampath D; Valdez R; White AM; Raol YH
Neuropharmacology; 2017 Sep; 123():126-135. PubMed ID: 28587899
[TBL] [Abstract][Full Text] [Related]
29. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.
Gharaylou Z; Tafakhori A; Agah E; Aghamollaii V; Kebriaeezadeh A; Hadjighassem M
CNS Drugs; 2019 Mar; 33(3):283-291. PubMed ID: 30784026
[TBL] [Abstract][Full Text] [Related]
30. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.
Pressler RM; Boylan GB; Marlow N; Blennow M; Chiron C; Cross JH; de Vries LS; Hallberg B; Hellström-Westas L; Jullien V; Livingstone V; Mangum B; Murphy B; Murray D; Pons G; Rennie J; Swarte R; Toet MC; Vanhatalo S; Zohar S;
Lancet Neurol; 2015 May; 14(5):469-77. PubMed ID: 25765333
[TBL] [Abstract][Full Text] [Related]
31. Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures.
Quinlan SMM; Rodriguez-Alvarez N; Molloy EJ; Madden SF; Boylan GB; Henshall DC; Jimenez-Mateos EM
Sci Rep; 2018 Jul; 8(1):9986. PubMed ID: 29968748
[TBL] [Abstract][Full Text] [Related]
32. Pre-Clinical Models of Acquired Neonatal Seizures: Differential Effects of Injury on Function of Chloride Co-Transporters.
Kang S; Kadam S
Austin J Cerebrovasc Dis Stroke; 2014; 1(6):. PubMed ID: 25590049
[TBL] [Abstract][Full Text] [Related]
33. Decreased spasticity of Baishaoluoshi Decoction through the BDNF/TrKB-KCC2 pathway on poststroke spasticity rats.
Xie L; Xie Y; Mao G; Cao S; Fang R; Zhou S; Jiang J; Yao T; Fan J; Liu D; Wu D; Ge J
Neuroreport; 2021 Oct; 32(14):1183-1191. PubMed ID: 34284448
[TBL] [Abstract][Full Text] [Related]
34. Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.
Shirayama Y; Yang C; Zhang JC; Ren Q; Yao W; Hashimoto K
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2449-58. PubMed ID: 26419294
[TBL] [Abstract][Full Text] [Related]
35. BDNF signaling in the rat cerebello-vestibular pathway during vestibular compensation: BDNF signaling in vestibular compensation.
Zhou L; Zhou W; Zhang S; Liu B; Liang P; Zhou Y; Zhou T; Zhang K; Leng Y; Kong W
FEBS J; 2015 Sep; 282(18):3579-91. PubMed ID: 26111610
[TBL] [Abstract][Full Text] [Related]
36. Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia.
Welzel B; Johne M; Löscher W
Epilepsy Behav; 2023 May; 142():109189. PubMed ID: 37037061
[TBL] [Abstract][Full Text] [Related]
37. Variability in Preferred Management of Electrographic Seizures in Neonatal Hypoxic Ischemic Encephalopathy.
McNally MA; Hartman AL
Pediatr Neurol; 2017 Dec; 77():37-41. PubMed ID: 28982530
[TBL] [Abstract][Full Text] [Related]
38. The temporal characteristics of seizures in neonatal hypoxic ischemic encephalopathy treated with hypothermia.
Lynch NE; Stevenson NJ; Livingstone V; Mathieson S; Murphy BP; Rennie JM; Boylan GB
Seizure; 2015 Dec; 33():60-5. PubMed ID: 26571073
[TBL] [Abstract][Full Text] [Related]
39. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
40. Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia.
Traa BS; Mulholland JD; Kadam SD; Johnston MV; Comi AM
Pediatr Res; 2008 Jul; 64(1):81-5. PubMed ID: 18391849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
